Drug Trial Radar · NCT00627640
Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa
Last checked: Nov 19, 2026Latest source record: Mar 29, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
549
Actual
Start
Feb 2009
Primary completion
Jan 2012
Study completion Mar 2012
Sponsor
- Lead sponsor
- Newron Pharmaceuticals SPAIndustry
- Sponsor type
- Industry
- First posted
- Mar 3, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 30 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Parkinson's Disease is a major neurodegenerative disorder in which there is a progressive loss of dopamine-containing neurons. The understanding that PD is a syndrome of dopamine (DA) deficiency led to the introduction in the clinical practice of L-dopa, a precursor of DA that crosses the blood brain barrier, and also to the use of selective inhibitors of MAO-B, the major DA metabolising enzyme in man. Safinamide is an inhibitor of MAO-B. This is a phase III trial to evaluate the efficacy and safety of safinamide (50 and 100 mg p.o. q.a.m.) compared to placebo as add-on therapy to a stable dose to levodopa in subjects with advance idiopathic Parkinson's Disease. The principal efficacy measure is the increase in mean daily "on" time during the 18-hr diary recording period.
Conditions
- Idiopathic Parkinson's Disease
Interventions
Safinimide 50-100 mg/dayDrug
Safinamide, (S)-(+)-2-\[4-(3-fluorobenzyloxy) benzylamino\] propanamide methanesulfonate, is an a-aminoamide derivative
Matching PlaceboDrug
Matching Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluate the change from baseline to W24 in daily "on" time ("on" time without dyskinesia plus "on" time with minor dyskinesia)Time frame: 24 weeks
Locations
121 sites in 21 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Barrow Neurological Institute
Phoenix, Arizona
Mayo Clinic Scottsdale
Scottsdale, Arizona
San Francisco Clinical Research Center
San Francisco, California
Parkinson's Institute
Sunnyvale, California
Institute for Neurodegenerative Disorders
New Haven, Connecticut
Parkinson's Disease and Movement Disorder Center
Boca Raton, Florida
Neurologic Consultants P.A.
Fort Lauderdale, Florida
University of Florida
Gainesville, Florida
Parkinson's Disease Treatment Center of SW Florida
Port Charlotte, Florida
Neurology Clinical Research Inc.
Sunrise, Florida
University Of South Florida Medical Center
Tampa, Florida
Wesley Woods Geriatric Center
Atlanta, Georgia
Columbus Research Institute
Columbus, Georgia
Northwestern University PD and Movement Disorders Center
Chicago, Illinois
Rush University Medical Center
Chicago, Illinois
University of Kansas Medical Center
Kansas City, Kansas
University of Maryland Medical Center
Baltimore, Maryland
Boston University School of Medicine
Boston, Massachusetts
Quest Research Institute
Bingham Farms, Michigan
Parkinson's Disease and Movement Disorder Center
Albany, New York
North Shore Medical Center
Manhasset, New York
Neurological Institute of New York
New York, New York
The Neurological Institute
Charlotte, North Carolina
Duke Movement Disorders Clinic
Durham, North Carolina
Pennsylvania Hospital
Philadelphia, Pennsylvania
Vanderbilt University Medical Center
Nashville, Tennessee
Baylor College of Medicine
Houston, Texas
Concord Repatriation General Hospital
Concord, Australia
Central Coast Neuroscience Research
East Gosford, Australia
Univ.Klinik Graz
Graz, Austria
Univ.Klinik Innsbruck
Innsbruck, Austria
Cliniques Universitaires Saint-Luc
Brussels, Belgium
U.Z Antwerpen
Edegem, Belgium
Jessa Ziekenhuis - Campus Virga Jesse
Hasselt, Belgium
ZNA Hoge Beuken
Hoboken, Belgium
Heilig Hart Roeselare - Campus westlaan
Roeselare, Belgium
AZ Sint-Augustinus
Wilrijk, Belgium
King David
Halifax, Canada
Kingston General Hospital
Kingston, Canada
Showing 40 of 121 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.